Silencing of human HTT by targeted CRISPR/dCas9-mediated epigenetic editing.
Saved in:
| Title: | Silencing of human HTT by targeted CRISPR/dCas9-mediated epigenetic editing. |
|---|---|
| Authors: | Tay YL; Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research (A*STAR), Immunos, Singapore, Singapore., Thomson SB; Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada., Hnatova S; Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research (A*STAR), Immunos, Singapore, Singapore., Ng S; Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research (A*STAR), Immunos, Singapore, Singapore., Teo SR; Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research (A*STAR), Immunos, Singapore, Singapore., McCallum R; Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada., Sim B; Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research (A*STAR), Immunos, Singapore, Singapore., Tarantini L; Department of Clinical Sciences and Community Health, EPIGET - Epidemiology, Epigenetics and Toxicology Laboratory, University of Milano, Milan, Italy., Tai FL; Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research (A*STAR), Immunos, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore., Bollati V; Department of Clinical Sciences and Community Health, EPIGET - Epidemiology, Epigenetics and Toxicology Laboratory, University of Milano, Milan, Italy., Loh M; Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research (A*STAR), Immunos, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore., Hayden MR; Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada., Leavitt BR; Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada., Pouladi MA; Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research (A*STAR), Immunos, Singapore, Singapore.; Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada.; Department of Medical Genetics, Djavad Mowafaghian Centre for Brain Health, Edwin S. H. Leong Centre for Healthy Aging, Faculty of Medicine, University of British Columbia, British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada. |
| Source: | Journal of Huntington's disease [J Huntingtons Dis] 2026 Aug; Vol. 15 (3), pp. 399-407. Date of Electronic Publication: 2026 Jan 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: IOS Press Country of Publication: United States NLM ID: 101589965 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-6400 (Electronic) Linking ISSN: 18796397 NLM ISO Abbreviation: J Huntingtons Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41570009 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Silencing of human HTT by targeted CRISPR/dCas9-mediated epigenetic editing. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tay+YL%22">Tay YL</searchLink>; Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research (A*STAR), Immunos, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Thomson+SB%22">Thomson SB</searchLink>; Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Hnatova+S%22">Hnatova S</searchLink>; Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research (A*STAR), Immunos, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Ng+S%22">Ng S</searchLink>; Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research (A*STAR), Immunos, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Teo+SR%22">Teo SR</searchLink>; Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research (A*STAR), Immunos, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22McCallum+R%22">McCallum R</searchLink>; Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Sim+B%22">Sim B</searchLink>; Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research (A*STAR), Immunos, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Tarantini+L%22">Tarantini L</searchLink>; Department of Clinical Sciences and Community Health, EPIGET - Epidemiology, Epigenetics and Toxicology Laboratory, University of Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Tai+FL%22">Tai FL</searchLink>; Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research (A*STAR), Immunos, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Bollati+V%22">Bollati V</searchLink>; Department of Clinical Sciences and Community Health, EPIGET - Epidemiology, Epigenetics and Toxicology Laboratory, University of Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Loh+M%22">Loh M</searchLink>; Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research (A*STAR), Immunos, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Hayden+MR%22">Hayden MR</searchLink>; Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Leavitt+BR%22">Leavitt BR</searchLink>; Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Pouladi+MA%22">Pouladi MA</searchLink>; Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research (A*STAR), Immunos, Singapore, Singapore.; Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada.; Department of Medical Genetics, Djavad Mowafaghian Centre for Brain Health, Edwin S. H. Leong Centre for Healthy Aging, Faculty of Medicine, University of British Columbia, British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101589965%22">Journal of Huntington's disease</searchLink> [J Huntingtons Dis] 2026 Aug; Vol. 15 (3), pp. 399-407. <i>Date of Electronic Publication: </i>2026 Jan 22. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22IOS+Press%22">IOS Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101589965 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-6400 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2218796397%22">18796397 </searchLink><i>NLM ISO Abbreviation: </i>J Huntingtons Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41570009 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1177/18796397251415368 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 399 Titles: – TitleFull: Silencing of human HTT by targeted CRISPR/dCas9-mediated epigenetic editing. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tay YL – PersonEntity: Name: NameFull: Thomson SB – PersonEntity: Name: NameFull: Hnatova S – PersonEntity: Name: NameFull: Ng S – PersonEntity: Name: NameFull: Teo SR – PersonEntity: Name: NameFull: McCallum R – PersonEntity: Name: NameFull: Sim B – PersonEntity: Name: NameFull: Tarantini L – PersonEntity: Name: NameFull: Tai FL – PersonEntity: Name: NameFull: Bollati V – PersonEntity: Name: NameFull: Loh M – PersonEntity: Name: NameFull: Hayden MR – PersonEntity: Name: NameFull: Leavitt BR – PersonEntity: Name: NameFull: Pouladi MA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2026 Aug Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1879-6400 Numbering: – Type: volume Value: 15 – Type: issue Value: 3 Titles: – TitleFull: Journal of Huntington's disease Type: main |
| ResultId | 1 |